{"analyses":[{"ciNumSides":"TWO_SIDED","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.1270","paramType":"Hazard Ratio (HR)","paramValue":"1.124","statisticalMethod":"Log Rank"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"8.00","upperLimit":"9.00","value":"8.00"},{"groupId":"OG001","lowerLimit":"7.00","upperLimit":"8.00","value":"8.00"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"659"},{"groupId":"OG001","value":"673"}],"units":"Participants"}],"description":"Time to independence from oxygen therapy in days.","dispersionType":"95% Confidence Interval","groups":[{"description":"Placebo administered orally QD with standard of care.","id":"OG000","title":"Placebo + SOC"},{"description":"4 mg baricitinib administered orally QD with standard of care.","id":"OG001","title":"Baricitinib + SOC"}],"paramType":"MEDIAN","populationDescription":"All randomized participants who had an ordinal scale score of 5 or 6 at baseline.","reportingStatus":"POSTED","timeFrame":"Day 1 to Day 28","title":"Time to Independence From Oxygen Therapy in Days","type":"SECONDARY","unitOfMeasure":"days"}